1 The physiology of piloerection is described and clinical experience is discussed.
2 The objective and subjective evidence for drug-induced piloerection by a number of drugs is given and, where it is known, their pharmacological mechanism is described.
3 The results are considered in relation to the hypothesis that drug-induced piloerection is only produced by drugs with α1-adrenoceptor agonist activity. For those drugs without the latter activity where piloerection is supported only by subjective evidence it is suggested that objective evidence should be sought.
4 The fact that there is no objective evidence that the classical α1-adrenoceptor agonist, phenylephrine, produces piloerection is found surprising and it is suggested that such evidence should be sought. If it is found that phenylephrine does not produce piloerection, then the possibility of the existence of a further α-agonist subgroup needs to be considered.
Get full access to this article
View all access options for this article.
References
1.
Allwood, M.J. & Ginsburg, J. (1962). Peripheral vascular effects of dopamine in man . Int. Cong. Series, no. 47, vol. 2, abstract no. 185. Amsterdam: Excerpta Medica.
2.
Anderson, K.-E., Ekman, G., Henriksson, L. & Ulmsten, U. (1983). The effect of midodrine and its active metabolite ST1059 on the human urethra in vitro an in vivo. Scand. J. Urol. Nephrol., 17, 261-265.
3.
Baylis, F.H. (1974). Reaction to phenoxybenzamine. Lancet, iii, 1514.
4.
Bowman, N.C. & Rand, M.J. (1980). Textbook of Pharmacology, 2nd edn, pp. 31.9/42.75. London: Blackwell Scientific Publications.
5.
Burn, J.H., Leach, E.H. & Rand, M.J. (1938). Piloerection by nicotine and chromaffin tissue . Proc. Physiol. Soc., 5-6 December 1938, 19P.
6.
Charney, D.S., Heninger, G.R. & Sternberg, D.E. (1982). Assessment of alpha2 adrenergic auto-receptor function in humans: effects of oral yohimbine. Life Sci., 30 (23), 2033-2041.
7.
Clark, D.W. & Goldberg, L.I. (1972). Guancydine, a new antihypertensive agent. Ann. Intern. Med., 76, 579-585.
8.
Constantine, J.W. & Lebel, W. (1980). Complete blockade by phenoxybenzamine of alpha1 but not of alpha2-vascular receptors in dogs and the effects of propranolol. Naunyn-SchmiedebergsArch. Pharmakol., 314, 149-156.
9.
Coon, J.M. & Rothman, S. (1939). Nature of the pilomotor response to acetyl-choline . Proc. Soc. Exp. Biol. Med., 42, 229-231.
10.
Coon, J.S. & Rothman, S. (1940). The nature of the pilomotor response to acetyl-choline. Some observations on the pharmacodynamics of the skin. J. Pharmacol. Exp. Ther., 68, 301-311.
Doxey, J.C., Leonie, W., Hersom, F. & Hersom, A.S. (1981). Studies on the pre- and postjunctional activities of alpha adrenoreceptor agonists and their cardiovascular effects in the anaesthetized rat. J. Auton. Pharmacol., 1, 157-169.
13.
Duke, M., Ames, R.P. & Abelmann, W.H. (1963). Haemodynamic effects of methoxamine in normal human subjects. Am. J. Med. Sci., 79, 301.
14.
Elliott, H.O. (1954). Textbook of the Nervous System, 2nd edn, p. 284. Philadelphia: J. B.Lippincott Co.
15.
Exton, J.H. (1985). Mechanisms involved in alpha-adrenergic phenomena . Am. J. Physiol., 248, E633-E647.
16.
Fariello, R., Agabiti-Rosei, E., Alicandri, C., Romanelli, C.A.G., Beschi, M., Castellano, M. & Muiesan, G. (1981). Clinical study of guanfacine in essential hypertensive patients. Curr. Ther. Res., 29 (6), 968-973.
Gellhorn, E. (1957). Autonomic Imbalance and the Hypothalamus. Implications for Physiology, Medicine, Psychology and Neuropsychiatry , pp. 248/269. University of Minnesota Press.
19.
Ghose, K. (1980). Assessment of peripheral adrenergic activity and its interaction with drugs in man. Eur. J. Clin. Pharmacol. , 17, 233-238.
20.
Goodwin, J.F. & Kaplan, S. (1951). Priscol in treatment of peripheral vascular disease . Br. Med. J., i, 1102.
21.
Grimson, K.S., Reardon, M.J., Marzoni, F.A. & Hendrix, J.P. (1948). The effects of priscol on peripheral vascular diseases, hypertension and circulation in patients. Ann. Surg. , 127, 968.
22.
Gumulka, S.W., Dinnendahl, V., Bartmus, D., Schonhofer, P. & Stock, K. (1977). On the mode of action of clonidine: relationship between effects on behaviour and cyclic nucleotide content in mouse brain. Naunyn-SchmiedebergsArch. Pharmacol., 298, 7-14.
23.
Hellmann, K. (1963a). The effect of temperature change on the isolated pilomotor muscles. J. Physiol., 169,621-629.
24.
Hellmann, K. (1963b). The isolated pilomotor muscles as an in vitro preparation. J. Physiol., 169, 603-620.
25.
Horwitz, O., Montgomery, H., Longaker, E.D. & Sayen, A. (1949). Effects of vasodilator drugs and other procedures on digital blood flow, cardiac output, blood pressure, pulse rate, body temperature and metabolic rate. Am. J. Med. Sci., 218, 669.
26.
Laws, H.W. (1964). Peripheral vasodilators in the treatment of macular degenerative changes in the eye. Can. Med. Assoc. J., 91, 325.
27.
Levy, G.P. & Richards, D.A. (1980). Labetalol. In P harmacology of Antihypertensive Drugs, ed. A. Scrimbine, p. 330. New York: Raven Press.
28.
Lewis, T. & Marvin, H.M. (1927-1928). Observation upon a pilomotor reaction in response to faradism. J. Physiol., 64, 87-106.
29.
Loh, L., Nathan, P.W., Schott, G.D. & Wilson, P.G. (1980). Effects of regional guanethidine infusions in certain painful states. J. Neurol. Neurosurg. Psychiatry, 43, 446-451.
30.
Lynn, R.B. (1950). Effects of priscol on the peripheral circulation . Lancet, iii, 676-678.
31.
Mackenzie, J. (1893). The 'pilomotor' or 'goose-skin' reflex. Brain, 16, 515-533.
32.
Martinand, A., Lardoux, H., Corvol, P. & Milliez, P. (1980). Essential arterial hypertension; effect of labetalol on blood pressure and renin-angiotensin system. Nouv. Presse Med., 9 (35), 2565-2568.
33.
Medvedev, B.A. (1977). Pharmacologic study of clofelin. Farmakol. Toksikol., 40 (3), 288-296.
34.
Möller, H. (1965). The vasoconstrictor and piloerector effect in human skin of dopamine and normetanephrine as compared with noradrenaline . J. Invest. Dermatol., 44 (2), 83-86.
35.
Myers, J., Morgan, T., Waga, S., Hodgson, M. & Adam, W. (1980). Long-term experience with labetalol. Med. J. Aust., 1, 665-666.
36.
Nathanson, M.H. & Miller, H. (1952). Clinical observations on a new epinephrine-like compound, methoxamine. Am. J. Med. Sci., 223, 270.
37.
Rogers, M.P. (1949). Use of a sympatholytic drug (Priscol). J. Am. Med. Assoc., 140, 273.
38.
Saunders, J., Miller, D.D. & Patil, P.N. (1974). Alpha adrenergic and histaminergic effects of tolazolinelike imidazolines. J. Pharmacol. Exp. Ther., 195 (2), 362-371.
39.
Saunamaki, K.I. (1974). Effect of the imidazoline-derivative ST-91 on heart rate and blood pressure in healthy man. Br. J. Clin. Pharmacol.., 1, 197-202.
40.
Tomas, C.V. & Salonga, R.M. (1979). Labetalol in the treatment of hypertension. Acta Med. Philipp., 15, 5-11.
41.
Van Zwieten, P.A. & Timmermans, P.B.M.W.M. (1983). Cardiovascular alpha2 receptors . J. Mol. Cell. Cardiol., 15, 717-733.
42.
Wakim, K.G., Peters, G.A. & Horton, B.T. (1950). The effects of a new sympatholytic drug (priscol) on the peripheral circulation in man. J. Lab. Clin. Med., 35, 50.
43.
Winter, C.A. (1962). Psychosomimetic compounds pharmacological and behavioural effects in animals. In Psychosematic Medicine. The First Hahnemann Symp., eds J. H. Nodine & J. H. Moyer, p. 333. NY: Lea and Febiger.
44.
Woosley, R.L. & Nies, A.S. (1976). Guanethidine. New Engl. J. Med. , 295 (19), 1053-1057.
45.
Youmans, W.B., Goodman, M.J. & Gould, J. (1947). Treatment of paroxysmal auricular or nodal tachycardia with the vasopressor drug neosynephrine. Proc. Soc. Exp. Biol. Med., 64, 380.
